chronic liver disease
Conditions
Interventions
None listed
Sponsors
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.NAFLD patients who underwent UGAP, CAP and PDFF within 3 months 2. As control subjects without steatosis, patients with chronic liver disease including viral hepatitis, NAFLD, autoimmune hepatitis, primary biliary cholangitis, and so on. 3.Patients who can follow instructions such as breath-holding.
Exclusion criteria
Exclusion criteria: 1.Patients without claustrophobia 2.Patients without magnetic substance or tattoo 3.Patients without pacemakers 4.Patients who are pregnant 5.Patients judged as inappropriate for the study by the study responsibility (share) physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We assess the accuracy of UGAP and CAP in assessing hepatic steatosis compared to PDFF | — |
Secondary
| Measure | Time frame |
|---|---|
| We verify whether UGAP and CAP can diagnose fatty liver (liver fat content 5% or more) | — |
Countries
Japan
Contacts
Public ContactKento Imajo
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Outcome results
None listed